Insider Transactions in Q3 2024 at Verrica Pharmaceuticals Inc. (VRCA)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 19
2024
|
Paul B Manning |
BUY
Bona fide gift
|
Indirect |
2,675,610
+50.0%
|
-
|
Sep 19
2024
|
Paul B Manning |
SELL
Bona fide gift
|
Indirect |
2,675,611
-100.0%
|
-
|
Aug 27
2024
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
9,021
-4.01%
|
$18,042
$2.46 P/Share
|
Aug 27
2024
|
Terry Kohler CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,899
-15.02%
|
$15,798
$2.46 P/Share
|
Aug 27
2024
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,993
-10.95%
|
$17,986
$2.46 P/Share
|
Aug 27
2024
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,601
-3.68%
|
$7,202
$2.46 P/Share
|
Aug 27
2024
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,530
-8.27%
|
$19,060
$2.46 P/Share
|
Aug 26
2024
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
24,979
-9.99%
|
$49,958
$2.66 P/Share
|
Aug 26
2024
|
Terry Kohler CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,820
-29.32%
|
$43,640
$2.66 P/Share
|
Aug 26
2024
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
24,709
-23.13%
|
$49,418
$2.66 P/Share
|
Aug 26
2024
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,888
-9.18%
|
$19,776
$2.66 P/Share
|
Aug 26
2024
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
26,183
-18.51%
|
$52,366
$2.66 P/Share
|
Jul 23
2024
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
91
-0.06%
|
$546
$6.98 P/Share
|
Jul 23
2024
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
86
-0.08%
|
$516
$6.98 P/Share
|
Jul 23
2024
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
115
-0.11%
|
$690
$6.98 P/Share
|
Jul 23
2024
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
154
-0.06%
|
$924
$6.98 P/Share
|
Jul 22
2024
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,649
-13.26%
|
$151,543
$7.06 P/Share
|
Jul 22
2024
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,421
-14.59%
|
$128,947
$7.06 P/Share
|
Jul 22
2024
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,461
-19.23%
|
$178,227
$7.06 P/Share
|
Jul 22
2024
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
32,469
-11.49%
|
$227,283
$7.06 P/Share
|